Posted in Flagyl on February 26, 2016



On 2016-01-26, the FDA announced that Baxter International is conducting a countermand on 0.9% Sodium Chloride Injection, Metronidazole Injection, And Clinimix E 5/15 directly to a possible particulate matter. The recalled products were sold in a state of being liable to the brand name(s) Baxter during an unspecified time period throughout the regions shown in the picture below.

In recent months, there own been 1 medical devices recalls to be ascribed to potential particulate matter, including sodium chloride, dextrose, and lactated ringer’s injections, and added. Additionally, there have been 4 drug and medical device recalls due to other freedom from disease hazards as well as 94 cheer recalls.

Label, Metronidazole Injection

Label, Metronidazole Injection

Label, Clinimix

Note: Images may not have existence available for every version. Please review the detailed description below.

Company Contact Information:

Name: Baxter International
Phone: 800-422-9837

Do you operate for a company involved with this countermand? Contact us to learn how you be possible to control data, information and ads shown in c~tinuance this page.

Detailed Recall Information

Regions Where Sold: Because the quarter was not specified, it is assumed that this work was available nationwide.

Product Description: 0.9% Sodium Chloride Injection, Metronidazole Injection, and Clinimix E 5/15

Brand Name(s): Baxter

Reason as antidote to Recall: Leaking containers and particulate sense

Official Recall Date: 2016-01-26


Additional complaint provided by the

Baxter International Inc. announced today it is voluntarily recalling four lots of intravenous (IV) solutions to the hospital/user horizontal surface due to the potential for leaking containers and particulate sense. Baxter was made aware of these issues being of the cl~s who the result of two complaints with a view to leaking containers and one customer murmur each for three lots due to particulate body. In each case, the issue was discovered prior to patient administration and there be seized of been no adverse events associated through these incidents reported to Baxter to fix the ~ of. Read More.

More information may exist available at

Sources may hold Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved by this or a related recall.

Efffects In people with chronic skin allergies, uncommon faction effects of lisinopril may occur.